Apyx Medical Corporation Engages with Investors at Key Conference
Apyx Medical Corporation Engages with Investors at Key Conference
Apyx Medical Corporation (NASDAQ: APYX) is excited to announce its participation in a significant healthcare conference dedicated to fostering connections with investors. This event will showcase the company’s advancements in medical technology and provide insightful discussions about its innovative products.
Overview of the Event Participation
Management at Apyx Medical is set to attend the Piper Sandler 36th Annual Healthcare Conference in December. This gathering provides a unique platform for industry leaders to connect and exchange valuable information. Apyx Medical’s leadership, including President and CEO Charlie Goodwin and Chief Financial Officer Matt Hill, will be actively involved in discussions and presentations.
Fireside Chat and Investor Meetings
The presence of Apyx Medical at this prominent conference is highlighted by a scheduled fireside chat featuring top executives. This interactive session is particularly anticipated as it allows investors to gain insights directly from the management team regarding the company’s direction and innovative technology.
Investor Engagement Strategies
Throughout the conference, Apyx Medical will also facilitate one-on-one meetings with investors. This personalized approach is aimed at fostering strong connections and addressing questions about the company’s initiatives, including their proprietary helium plasma technology and its applications in the medical field.
Innovative Technology by Apyx Medical
Apyx Medical Corporation is recognized for its cutting-edge energy technology solutions, particularly through its Renuvion® and J-Plasma® product lines. These technologies revolutionize cosmetic and surgical procedures, offering unparalleled capabilities by delivering controlled heat to tissue.
Clinical Backing and Effectiveness
The effectiveness of Apyx Medical’s technologies is supported by extensive clinical documentation, numbering over 90 clinical papers. This evidence substantiates the efficacy of Renuvion and J-Plasma in achieving optimal surgical outcomes. This credibility elevates the company’s standing in the medical community and assures both practitioners and patients of the quality and reliability of its products.
Collaboration and Expertise
Beyond its proprietary products, Apyx Medical Corporation collaborates with other medical device manufacturers through OEM agreements, leveraging its expertise in creating unique waveforms. This strategic partnership model allows Apyx to expand its reach in the medical technology sphere, facilitating further innovation and enhancing healthcare delivery.
Investor Relations and Further Information
For those interested in learning more about Apyx Medical Corporation, comprehensive information regarding its innovative products and corporate initiatives can be acquired through their official website. Apyx Medical places a strong emphasis on transparency, particularly for investors and stakeholders to remain informed about the company's progress and future opportunities.
Contact for Investor Relations
For any inquiries regarding investor relations, Jeremy Feffer, Managing Director at LifeSci Advisors, is available to assist. You can reach him at 212-915-2568 or via email.
Frequently Asked Questions
What is Apyx Medical Corporation known for?
Apyx Medical Corporation specializes in advanced energy technology, particularly through its helium plasma and radiofrequency products sold as Renuvion and J-Plasma.
What key event is Apyx Medical participating in?
The company will participate in the Piper Sandler 36th Annual Healthcare Conference, engaging with investors and discussing its innovative technologies.
Who are the key executives attending the conference?
Charlie Goodwin, the CEO, and Matt Hill, the CFO, will represent the company at the event and facilitate discussions with investors.
How does Apyx Medical support its product efficacy?
The effectiveness of Apyx Medical’s technologies is backed by over 90 clinical documents, providing substantial validation in the medical community.
Where can I find more information about Apyx Medical?
For additional details, visit Apyx Medical Corporation’s official website or reach out to the investor relations contact for direct inquiries.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.